/360_F_358094748_shwLUwwLKKlF3QqN6lh9ejwU2MAelz2T.jpg)
/360_F_358094748_shwLUwwLKKlF3QqN6lh9ejwU2MAelz2T.jpg)
By Sacred Leaves Global Medical News
Scientists believe that a major breakthrough in the treatment of Alzheimer’s disease could happen within 5–10 years. In the future, it may be possible not only to slow the disease down, but also to prevent it — and eventually treat patients who already have symptoms.
Researchers at the University of Edinburgh study living human brain tissue, donated by patients during neurosurgical procedures. This unique approach allows them to directly observe how Alzheimer’s disease damages the connections between brain cells responsible for memory and thinking.
Some medications, such as lecanemab and donanemab, are already available and can slow disease progression, although their effects are still limited. Scientists see these drugs as an important first step toward more effective treatments.
Current research suggests that Alzheimer’s disease involves not only toxic proteins, but also the immune system, inflammation, blood vessels, and genetic factors. As a result, future treatments are likely to target the disease from multiple angles.
Despite growing optimism, all potential therapies must be proven through clinical trials. The human brain is extremely complex, but existing evidence gives scientists real hope for meaningful progress.
Sources: https://www.bbc.com/news/articles/cn4dnwky48wo